Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Consulting agrmnt
Inv. presentation
Quarterly results
Asset acq. complete
Director departure
CC transcript
Asset disposition
Acq. announced
|
|
Protagenic Therapeutics, Inc.\new (PTIX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/12/2016 |
8-K
| Acquisition/merger/asset purchase announced, Entered into consulting agreement|
Docs:
|
"Agreement and Plan of Merger and Reorganization, by and among Atrinsic, Inc. a Delaware corporation, Protagenic Acquisition Corp., a Delaware corporation and Protagenic Therapeutics, Inc., a Delaware corporation",
"Certificate of Merger as filed with the Delaware Secretary of State effective February 12, 2016",
"PT00114 is rapidly cleared from the patient's bloodstream (its “half life” is 5-10min if given intravenously (IV), 20-30 minutes if given subcutanesouly (SC)",
"PT00114 is rapidly cleared from the patient's bloodstream (its “half life” is 5-10min if given intravenously (IV), 20-30 minutes if given subcutanesouly (SC)",
"Form of Warrant of Protagenic Therapeutics, Inc",
"Chief Operating Officer, Interim President",
"PT00114 naturally crosses the blood brain barrier, while certain other TRD drugs do not naturally do that and therefore must be given at higher doses so that any of them make it into the patient's brain",
"PT00114 naturally crosses the blood brain barrier, while certain other TRD drugs do not naturally do that and therefore must be given at higher doses so that any of them make it into the patient's brain",
"PT00114 naturally crosses the blood brain barrier, while certain other TRD drugs do not naturally do that and therefore must be given at higher doses so that any of them make it into the patient's brain",
"PT00114 naturally crosses the blood brain barrier, while certain other TRD drugs do not naturally do that and therefore must be given at higher doses so that any of them make it into the patient's brain" |
|
| 12/29/2011 |
8-K
| Form 8-K - Current report |
|
|